Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with <i>KRAS G12C</i> mutationJayesh Desai, Manish Patel, Erminia Massarelli et al.|Cancer Research|2023Cited by 10
A phase 1/2 study of JK06, a 5T4 antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancer.Nuria Kotecki, Naimish Pandya, Sylvie Rottey et al.|Journal of Clinical Oncology|2025Cited by 0